Welireg OverviewBelzutifan, sold under the brand name Welireg, is a medication used for the treatment of von Hippel–Lindau disease-associated renal cell carcinoma. It is taken by mouth. The most common side effects include decreased hemoglobin, anemia, fatigue, increased creatinine, headache, dizziness, increased glucose, and nausea. Belzutifan is an hy...
Read more Welireg Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Belzutifan
Recent Welireg Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 40mg
NDC Database Records for Welireg: (1 result)Sorted by National Drug Code
- 0006-5331 Welireg 40 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.